Improvement of Osseointegration by Ultraviolet And/or Simvastatin Treatment on Titanium Implants with or Without Bone Graft Materials
Overview
Affiliations
We evaluated and compared ultraviolet (UV) treatment and simvastatin (SIM) immersion effects on the osseointegration of sandblasted, large-grit, acid-etched (SLA) titanium dental implants at two different time points in rabbit tibias, with or without xenogenic bone graft materials. The surface alteration on simvastatin treatment titanium discs was analyzed using an infrared spectrometer. Implants were categorized into four groups according to the surface treatment type. Twelve rabbits received two implants per tibia. A tibial defect model was created using a trephine bur, with implants in contact with the bone surface and bovine bone graft materials for gap filling. The rabbits were sacrificed after 2 or 4 weeks. UV treatment or SIM immersion increased the bone-to-implant contact (BIC) on nongrafted sides, and both increased the BIC and bone area (BA) on grafted sides. The application of both treatments did not result in higher BIC or BA than a single treatment. At two different time points, BIC in the nongrafted sides did not differ significantly among the UV and/or SIM treated groups, whereas BA differed significantly. UV or SIM treatment of SLA titanium implants accelerates osseointegration in tibias with or without xenogenic bone graft materials. The combination of both treatments did not show synergy.
Ghambaryan N, Yessayan L, Hakobyan G Odontology. 2024; 112(4):1316-1325.
PMID: 38526626 DOI: 10.1007/s10266-024-00926-0.
Tseng K, Shiu S, Hung C, Chan Y, Chee T, Huang P Int J Mol Sci. 2024; 25(2).
PMID: 38255941 PMC: 10815485. DOI: 10.3390/ijms25020862.
Abu Alfaraj T, Al-Madani S, Alqahtani N, Almohammadi A, Alqahtani A, AlQabbani H Cureus. 2023; 15(10):e47943.
PMID: 38034153 PMC: 10685082. DOI: 10.7759/cureus.47943.
Enhanced osseointegration of drug eluting nanotubular dental implants: An and study.
Chauhan P, Srivastava A, Bhati P, Chaturvedi M, Patil V, Kunnoth S Bioact Mater. 2023; 28:432-447.
PMID: 37426894 PMC: 10329101. DOI: 10.1016/j.bioactmat.2023.06.003.
Ghambaryan N, Jilavyan A, Burnazyan S, Khudaverdyan M, Gegham T, Hakobyan G J Maxillofac Oral Surg. 2023; 22(Suppl 1):64-75.
PMID: 37041958 PMC: 10082880. DOI: 10.1007/s12663-022-01798-z.